Vesalius Pharma

Company Description

Manufacturer and Exporter of Indometacina inyectable, Indomethacin ijection, Kanamycin, Cycloserin, Amphotericin B liposomal, Capreomycin, Amphotericin B, Vesalius Pharma, was incorporated in 2011 with an investment of Approx 0.5 Billion US Dollar. Having an export rate of almost US$50 Million - US$100 Million in recent times, Vesalius Pharma has been fortifying its network as a significant supplier of Amphotericin B products in different parts of the world. Vesalius Pharma has been operating since 9 Years . The market share of Vesalius Pharma is approximately around Australia,Canada,South Korea,Mexico,United Kingdom. However, Oceanic and European markets remain untouched, but the industry is planning to open its doors in the European and Oceanic market. Vesalius Pharma is located in Bogota, Distrito Capital de Bogota, Colombia and is a Corporation Limited Liability Company entity with Own Lisence. The industry has been slowly making waves in the export world with its top-quality products and plans to tap some of the most significant markets in Oceania and Europe.